Bone disease in patients before and after cardiac transplantation

Bone Disease of Organ Transplantation

Volumn , Issue , 2005, Pages 287-301

  Cohen, Adi ^a   Shane, Elizabeth ^b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35648933946     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012183502-6/50017-1     Document Type: Chapter

References (55)

1. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The registry of the International Society for Heart and Lung Transplantation: sixteenth official report. J Heart Lung Transplant. 2001, 20:805-815.
2. Shane E., Mancini D., Aaronson K., et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997, 103:197-207.
3. Kerschan-Schindl K., Strametz-Juranek J., Heinze G., et al. Pathogenesis of bone loss in heart transplant candidates and recipients. J Heart Lung Transplant. 2003, 22:843-850.
4. Leidig-Bruckner G., Hosch S., Dodidou P., et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet. 2001, 357:342-347.
5. Berguer D.G., Krieg M.A., Thiebaud D., et al. Osteoporosis in heart transplant recipients: a longitudinal study. Transplant Proc. 1994, 26:2649-2651.
6. Garcia-Delgado I., Prieto S., Gil-Fraguas L., Robles E., Rufilanchas J.J., Hawkins F. Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int. 1997, 60:155-159.
7. Bianda T., Linka A., Junga G., et al. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int. 2000, 67:116-121.
8. Muchmore J.S., Cooper D.K., Ye Y., Schlegel V.T., Zuhdi N. Loss of vertebral bone density in heart transplant patients. Transplant Proc. 1991, 23:1184-1185.
9. Lee A.H., Mull R.L., Keenan G.F., et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med. 1994, 96:35-41.
10. Schleithoff S.S., Zittermann A., Stuttgen B., et al. Low serum levels of intact osteocalcin in patients with congestive heart failure. J Bone Miner Metab. 2003, 21:247-252.
11. Nishio K., Mukae S., Aoki S., et al. Congestive heart failure is associated with the rate of bone loss. J Intern Med. 2003, 253:439-446.
12. Rosen, H.N. Drugs that affect bone metabolism, in Up ToDate, Rose, B.D., ed. 2003, Wellesley, MA: Up ToDate.
13. Dahlman T.C., Sjoberg H.E., Ringertz H. Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol. 1994, 170:1315-1320.
14. Barbour L.A., Kick S.D., Steiner J.F., et al. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol. 1994, 170:862-869.
15. Dahlman T.C. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 1993, 168:1265-1270.
16. Muir J.M., Andrew M., Hirsh J., et al. Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood. 1996, 88:1314-1320.
17. Caraballo P.J., Heit J.A., Atkinson E.J., et al. Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med. 1999, 159:1750-1756.
18. Jamal S.A., Browner W.S., Bauer D.C., Cummings S.R. Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1998, 128:829-832.
19. Tromp A.M., Ooms M.E., Popp-Snijders C., Roos J.C., Lips P. Predictors of fractures in elderly women. Osteoporos Int. 2000, 11:134-140.
20. Heidrich F.E., Stergachis A., Gross K.M. Diuretic drug use and the risk for hip fracture. Ann Intern Med. 1991, 115:1-6.
21. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res. 1996, 11:1-7.
22. Shane E., Rivas M.C., Silverberg S.J., Kim T.S., Staron R.B., Bilezikian J.P. Osteoporosis after cardiac transplantation. Am J Med. 1993, 94:257-264.
23. Glendenning P., Kent G.N., Adler B.D., et al. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry. Clin Endocrinol (Oxf) 1999, 50:347-355.
24. Hofle G., Holzmuller H., Gouya G., et al. Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone. Transpl Int. 2003, 16:523-528.
25. Rich G.M., Mudge G.H., Laffel G.L., LeBoff M.S. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant. 1992, 11:950-958.
26. Fahrleitner A., Prenner G., Leb G., et al. Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. Bone. 2003, 32:96-106.
27. Guo C.Y., Johnson A., Locke T.J., Eastell R. Mechanisms of bone loss after cardiac transplantation. Bone. 1998, 22:267-271.
28. Braith R.W., Howard C., Fricker F.J., Mitchell M., Edwards D.G. Glucocorticoid-induced osteopenia in adolescent heart transplant recipients. J Heart Lung Transplant. 2000, 19:840-845.
29. Cohen A., Addonizio L.J., Lamour J.M., et al. Osteoporosis in adult survivors of adolscent cardiac transplantation may be related to hyperparathyroidism, mild renal insufficiency and increased bone turnover. J Heart Lung Transplant. 2004, In Review.
30. Shane E., Rivas M., McMahon D.J., et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab. 1997, 82:1497-1506.
31. Van Cleemput J., Daenen W., Nijs J., Geusens P., Dequeker J., Vanhaecke J. Timing and quantification of bone loss in cardiac transplant recipients. Transpl Int. 1995, 8:196-200.
32. Thiebaud D., Krieg M.A., Gillard-Berguer D., Jacquet A.F., Goy J.J., Burckhardt P. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest. 1996, 26:549-555.
33. Sambrook P.N., Kelly P.J., Fontana D., et al. Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int. 1994, 4:273-276.
34. Shane E., Addesso V., Namerow P.B., et al. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med. 2004, 350(8):767-776.
35. Sambrook P.N., Kelly P.J., Keogh A.M., et al. Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant. 1994, 13:116-120. discussion 121.
36. Link T.M., Lotter A., Beyer F., et al. Changes in calcaneal trabecular bone structure after heart transplantation: an MR imaging study. Radiology. 2000, 217:855-862.
37. Shane E., Rivas M., Staron R.B., et al. Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab. 1996, 81:1740-1746.
38. Delmas P.D., Wilson D.M., Mann K.G., Riggs B.L. Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab. 1983, 57:1028-1030.
39. Lane N.E., Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am. 1998, 27:465-483.
40. Dempster D.W. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 1989, 4:137-141.
41. Boncimino K., McMahon D.J., Addesso V., Bilezikian J.P., Shane E. Magnesium deficiency and bone loss after cardiac transplantation. J Bone Miner Res. 1999, 14:295-303.
42. Krieg M.A., Seydoux C., Sandini L., et al. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study. Osteoporos Int. 2001, 12:112-116.
43. Van Cleemput J., Daenen W., Geusens P., Dequeker P., Van De Werf F., VanHaecke J. Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D. Transplantation. 1996, 61:1495-1499.
44. Stempfle H.U., Werner C., Siebert U., et al. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation. 2002, 73:547-552.
45. Henderson K., Eisman J., Keogh A., et al. Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res. 2001, 16:565-571.
46. Sambrook P., Henderson N.K., Keogh A., et al. Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res. 2000, 15:1818-1824.
47. Shane E., Rodino M.A., McMahon D.J., et al. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. J Heart Lung Transplant. 1998, 17:1089-1096.
48. Addesso V., Cohen A., McMahon D.J., et al. Bone density is stable after discontinuing antiresorptive therapy during the second year after cardiac transplantation. J Bone Miner Res. 2003, 18:S174.
49. Ippoliti G., Pellegrini C., Campana C., et al. Clodronate treatment of established bone loss in cardiac recipients: a randomized study. Transplantation. 2003, 75:330-334.
50. Dodidou P., Bruckner T., Hosch S., et al. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation. Osteoporos Int. 2003, 14:82-89.
51. Braith R.W., Magyari P.M., Fulton M.N., Aranda J., Walker T., Hill J.A. Resistance exercise training and alendronate reverse glucocorticoid-induced osteoporosis in heart transplant recipients. J Heart Lung Transplant. 2003, 22:1082-1090.
52. Fahrleitner A., Prenner G., Tscheliessnigg K.H., et al. Testosterone supplementation has additional benefits on bone metabolism in cardiac transplant recipients receiving intravenous bisphosphonate treatment: a prospective study. J Bone Miner Metab. 2002, 17:S388.
53. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama. 2002, 288:321-333.
54. Valimaki M.J., Kinnunen K., Tahtela R., et al. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin. Osteoporos Int. 1999, 10:128-136.
55. Cremer J., Struber M., Wagenbreth I., et al. Progression of steroid-associated osteoporosis after heart transplantation. Ann Thorac Surg. 1999, 67:130-133.